Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia-Reference-Cited by-同舟云学术

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia

Published:2017-02 Issue:2 Volume:7 Page:e523-e523
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Richter-Pechańska P,Kunz J B,Hof J,Zimmermann M,Rausch T^ORCID,Bandapalli O R,Orlova E,Scapinello G,Sagi J C,Stanulla M,Schrappe M,Cario G,Kirschner-Schwabe R^ORCID,Eckert C,Benes V^ORCID,Korbel J O,Muckenthaler M U,Kulozik A E

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj20173.pdf

Reference54 articles.

1. Schrappe M, Valsecchi MG, Bartram CR, Schrauder A, Panzer-Grumayer R, Moricke A et al. Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood 2011; 118: 2077–2084.

2. von Stackelberg A. Charité Universitätsmedizin Berlin, 2015, with reference to the trials ALL-REZ BFM 83 - 2002.

3. Locatelli F, Schrappe M, Bernardo ME, Rutella S . How I treat relapsed childhood acute lymphoblastic leukemia. Blood 2012; 120: 2807–2816.

4. Henze G, von Stackelberg A, Eckert C . ALL-REZ BFM—the consecutive trials for children with relapsed acute lymphoblastic leukemia. Klin Padiatr 2013; 225: S73–S78.

5. Tallen G, Ratei R, Mann G, Kaspers G, Niggli F, Karachunsky A et al. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. J Clin Oncol 2010; 28: 2339–2347.

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis;Blood;2024-06-27

2. Cytogenomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals TCR rearrangements as predictive factors for exceptional prognosis;Molecular Cytogenetics;2024-05-23

3. A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID;Nature Communications;2024-04-30

4. Conserved helical motifs in the Ikaros IDR mediate NuRD interaction and transcriptional repression;2024-02-29

5. Pdx1 expression in hematopoietic cells activates Kras-mutation to drive leukemia in KC (Pdx1-Cre; LSL-Kras^G12D/+) mice;Leukemia & Lymphoma;2023-04-20